Ims Health Newswire

Ims Health Newswire

Comprehensive Real-Time News Feed for Ims Health.

Results 1 - 20 of 99 in Ims Health

  1. Information Technology Services Stocks Scanner - Computer Sciences,...Read the original story

    Wednesday Jun 8 | Customer Interaction Solutions

    The gains were broad based as eight out of nine sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Computer Sciences Corporation , IMS Health Holdings Inc. , NCR Corporation , and Unisys Corporation .

    Comment?

  2. Privacy Analytics Acquired by IMS HealthRead the original story

    May 26, 2016 | Customer Interaction Solutions

    The transaction combines Privacy Analytics' leading edge expertise in health data anonymization and de-identification with IMS Health's broad range of healthcare information, technology and services solutions, particularly its Real-World Evidence capabilities. IMS Health's mission-critical anonymous information and technical strength in providing its life sciences clients with R&D and commercial solutions positions Privacy Analytics to continue to expand its suite of innovative data governance software and expertise on a global scale.

    Comment?

  3. BioSyent Signs Exclusive Distribution Agreement for Two New Cardiovascular ProductsRead the original story w/Photo

    May 25, 2016 | Market Wire

    ... intends to submit the dossier seeking marketing approval of the products to Health Canada in 2016. According to IMS Health data, the cardiovascular market in Canada is valued at CAD $1.6 billion and grew at an annualized rate of +1.9% in 2015. Based ...

    Comment?

  4. Lawsuit for Investors in IMS Health Holdings Inc (NYSE:IMS) in Effort to Halt the Takeover FiledRead the original story w/Photo

    May 23, 2016 | SBWire

    An investor in shares of IMS Health Holdings Inc filed a lawsuit in effort to halt the proposed takeover of Danbury, CT based IMS Health Holdings Inc by Quintiles Transnational Holdings. Investors who purchased shares of IMS Health Holdings Inc and currently hold any of those NYSE:IMS shares have certain options and should contact the Shareholders Foundation at [email protected] or call 858-779-1554.

    Comment?

  5. Achoo you -- tree pollen in late-blooming spring keeps noses runnyRead the original story w/Photo

    May 12, 2016 | MLive.com

    ... days across Michigan is coming mostly from ash, maple and birch trees, according to pollen.com , a website of IMS Health Inc. A good rule of thumb for the end of the tree pollen season is to watch for the cottonwoods to bloom, Horbal said. When they ...

    Comment?

  6. The Takeover of IMS Health Holdings Inc (NYSE:IMS) Is Under Investigation for InvestorsRead the original story w/Photo

    May 11, 2016 | SBWire

    The takeover of Danbury, CT based IMS Health Holdings Inc is under investigation over potential wrongdoing. The investigation was announced on behalf of investors, who currently hold NYSE:IMS shares, concerning whether the takeover of IMS Health Holdings Inc by Quintiles Transnational Holdings is unfair.

    Comment?

  7. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story w/Photo

    May 7, 2016 | Business Wire

    ... fiduciary duty and other vi... INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of IMS Health Holdings, Inc. and Encourages Investors to Contact the Firm for Additional Information )--The securities litigation law firm ...

    Comment?

  8. IMS Health Holdings' (IMS) CEO Ari Bousbib on Q1 2016 Results - Earnings Call TranscriptRead the original story w/Photo

    May 3, 2016 | Seeking Alpha

    Welcome to the IMS Health First Quarter 2016 Earnings Conference Call. [Operator Instructions].

    Comment?

  9. IMS Health Holdings (IMS) Ari Bousbib on Q1 2016 Results - Earnings Call TranscriptRead the original story w/Photo

    May 3, 2016 | Seeking Alpha

    Ladies and gentlemen, thank you for standing by. Welcome to the IMS Health First 2016 Earnings Conference Call.

    Comment?

  10. Why These Five Stocks Are on the Move Today?Read the original story

    May 3, 2016 | Insider Monkey

    ... from China and a stronger yen. Five stocks that are making the headlines today are Apple Inc. (NASDAQ : AAPL ) , IMS Health Holdings Inc (NYSE : IMS ) and Quintiles Transnational Holdings Inc (NYSE : Q ) , Rayonier Advanced Materials Inc (NYSE : ...

    Comment?

  11. IMS Health to Announce First-Quarter 2016 Results on May 4, 2016Read the original story

    Apr 20, 2016 | Freshnews

    IMS Health Holdings, Inc. will issue its first-quarter 2016 financial results before the market opens on Wednesday, May 4, 2016. The earnings release and accompanying financial information will be posted on the IMS Health Investor Relations website at http://ir.imshealth.com .

    Comment?

  12. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Apr 18, 2016 | Business Wire

    Debuts at... )--IMS Health has been named to the International Association of Outsourcing Professionals' 2016 Global Outsourcing 100A List, which recognizes the w... Consolidated Tomoka Announces Contract for Sale of 500,000 Acres of Subsurface Interests for $24 Million and a $9 Million Land Sales Contract )--Consolidated-Tomoka Land Co.

    Comment?

  13. IMS Health Named a Leading Outsourcing Provider by International...Read the original story

    Apr 18, 2016 | Freshnews

    IMS Health has been named to the International Association of Outsourcing Professionals' 2016 Global Outsourcing 100 List, which recognizes the world's best service providers across a range of industries. The Global Outsourcing 100 enables companies to evaluate potential service providers based on key quality metrics.

    Comment?

  14. Biosimilars: A New Wave of Generic DrugsRead the original story

    Apr 18, 2016 | Minyanville

    Thus far in the 21st century, the rise of biologic drugs [i] has been a major theme in the global pharmaceutical industry. According to IMS Health, global biologic sales increased from nearly $46 billion in 2002 to $160 billion in 2012 with expected sales in 2017 of $221 billion [ii] .

    Comment?

  15. Biosyent Inc. (RX) Insider Acquires C$14,014.00 in StockRead the original story w/Photo

    Mar 29, 2016 | AmericanBankingNews.com

    Biosyent Inc. insider Alfred D'souza acquired 2,000 shares of the company's stock in a transaction dated Tuesday, March 29th. The stock was acquired at an average price of C$7.01 per share, for a total transaction of C$14,014.00.

    Comment?

  16. American Medical News ceases publication after 55-year runRead the original story

    Mar 28, 2016 | American Medical Association

    ... fell by 31%, from $470 million in 2007 to $322 million in 2011, the most recent year of data made available by IMS Health, a market-analysis firm. Experts often have blamed the steep drops in ad spending on the number of top-selling drugs going off ...

    Comment?

  17. Insider Selling: Biosyent Inc. (RX) Director Sells 2,000 Shares of StockRead the original story w/Photo

    Mar 24, 2016 | AmericanBankingNews.com

    Biosyent Inc. Director Milt Wakefield sold 2,000 shares of the company's stock in a transaction dated Thursday, March 24th. The shares were sold at an average price of C$7.10, for a total transaction of C$14,200.00.

    Comment?

  18. Milt Wakefield Sells 2,000 Shares of Biosyent Inc. (RX) StockRead the original story w/Photo

    Mar 23, 2016 | AmericanBankingNews.com

    Biosyent Inc. Director Milt Wakefield sold 2,000 shares of the firm's stock in a transaction dated Wednesday, March 23rd. The shares were sold at an average price of C$7.10, for a total transaction of C$14,200.00.

    Comment?

  19. Biosyent Inc. (RX) Director Sells C$28,160.00 in StockRead the original story w/Photo

    Mar 22, 2016 | AmericanBankingNews.com

    Biosyent Inc. Director Milt Wakefield sold 4,000 shares of the company's stock in a transaction dated Monday, March 21st. The stock was sold at an average price of C$7.04, for a total value of C$28,160.00.

    Comment?

  20. Milt Wakefield Sells 2,000 Shares of Biosyent Inc. (RX) StockRead the original story w/Photo

    Mar 16, 2016 | AmericanBankingNews.com

    Biosyent Inc. Director Milt Wakefield sold 2,000 shares of the company's stock in a transaction on Wednesday, March 16th. The shares were sold at an average price of C$6.87, for a total transaction of C$13,740.00.

    Comment?